mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0005 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
XMD15-27 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |